Gene: CCDC92
Official Full Name: coiled-coil domain containing 92provided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be involved in innate immune response and regulation of defense response to virus. Located in centriole; centrosome; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26123 | CCDC92 Knockout cell line (HeLa) | Human | CCDC92 | 1:3~1:6 | Negative | Online Inquiry |
KO26124 | CCDC92 Knockout cell line (HCT 116) | Human | CCDC92 | 1:2~1:4 | Negative | Online Inquiry |
KO26125 | CCDC92 Knockout cell line (HEK293) | Human | CCDC92 | 1:3~1:6 | Negative | Online Inquiry |
KO26126 | CCDC92 Knockout cell line (A549) | Human | CCDC92 | 1:3~1:4 | Negative | Online Inquiry |
CCDC92 Gene Knockout Cell Lines represent a cutting-edge tool in genetic research and cellular biology, specifically designed to facilitate the study of the CCDC92 gene's role in various biological processes. These cell lines are engineered to have a complete ablation of the CCDC92 gene, enabling researchers to observe the cellular and phenotypic changes that occur in its absence. By leveraging CRISPR-Cas9 technology, these knockout cell lines provide a robust model system to investigate gene function, interaction, and regulation in a controlled environment.
The primary function of CCDC92 Gene Knockout Cell Lines lies in their ability to mimic the specific genetic deficiency associated with the CCDC92 gene, which is known to play a crucial role in cilia and centrosome functions. This characteristic makes these cell lines indispensable for research in areas such as developmental biology, cancer biology, and the study of ciliopathies. Investigating the pathways influenced by CCDC92 can unveil critical insights into cell cycle regulation and signaling pathways, enhancing our understanding of numerous pathological conditions.
In terms of scientific importance, these knockout cell lines are vital for screening drugs and potential therapeutic agents targeting diseases linked to CCDC92 dysregulation. Researchers benefit from precise and reproducible results when using our knockout models, making them an indispensable resource in both academic and clinical research settings.
Compared to alternatives like siRNA knockdown methods, which can be transient and less stable, our CCDC92 Gene Knockout Cell Lines provide a permanent genetic alteration, ensuring consistent experimental conditions and reliable data. Additionally, our cell lines are developed under stringent quality control measures, ensuring optimal viability and differentiation capabilities.
For researchers and clinicians striving to delve deeper into genetic functions and their implications in health and disease, CCDC92 Gene Knockout Cell Lines represent a unique and powerful tool. Our commitment to quality and innovation underscores our expertise, positioning us as a trusted provider of biological products. We empower the scientific community to advance their research with confidence and precision, paving the way for discoveries that can lead to transformative treatment strategies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.